Trial intelligence / Profile preview

Preventive nalbuphine analgesia for visceral pain after laparoscopic cholecystectomy

ChiCTR1800014379Phase 4Recruiting

Sponsor
The Second Affiliated Hospital of Anhui Medical University
Start
Feb 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of nalbuphine in postoperative pain (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: VAS score. Started Feb 2018; status: recruiting.

02

Drugs

nalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR1800014379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800014379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call